Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain
Sangsu Bang, … , Zhen-Zhong Xu, Ru-Rong Ji
Sangsu Bang, … , Zhen-Zhong Xu, Ru-Rong Ji
Published July 16, 2018
Citation Information: J Clin Invest. 2018;128(8):3568-3582. https://doi.org/10.1172/JCI99888.
View: Text | PDF
Research Article Inflammation Neuroscience

GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain

  • Text
  • PDF
Abstract

The mechanisms of pain induction by inflammation have been extensively studied. However, the mechanisms of pain resolution are not fully understood. Here, we report that GPR37, expressed by macrophages (MΦs) but not microglia, contributes to the resolution of inflammatory pain. Neuroprotectin D1 (NPD1) and prosaptide TX14 increase intracellular Ca2+ (iCa2+) levels in GPR37-transfected HEK293 cells. NPD1 and TX14 also bind to GPR37 and cause GPR37-dependent iCa2+ increases in peritoneal MΦs. Activation of GPR37 by NPD1 and TX14 triggers MΦ phagocytosis of zymosan particles via calcium signaling. Hind paw injection of pH-sensitive zymosan particles not only induces inflammatory pain and infiltration of neutrophils and MΦs, but also causes GPR37 upregulation in MΦs, phagocytosis of zymosan particles and neutrophils by MΦs in inflamed paws, and resolution of inflammatory pain in WT mice. Mice lacking Gpr37 display deficits in MΦ phagocytic activity and delayed resolution of inflammatory pain. Gpr37-deficient MΦs also show dysregulations of proinflammatory and antiinflammatory cytokines. MΦ depletion delays the resolution of inflammatory pain. Adoptive transfer of WT but not Gpr37-deficient MΦs promotes the resolution of inflammatory pain. Our findings reveal a previously unrecognized role of GPR37 in regulating MΦ phagocytosis and inflammatory pain resolution.

Authors

Sangsu Bang, Ya-Kai Xie, Zhi-Jun Zhang, Zilong Wang, Zhen-Zhong Xu, Ru-Rong Ji

×

Figure 2

NPD1 induces iCa2+ increases in HEK293 cells and MΦs via GPR37.

Options: View larger image (or click on image) Download as PowerPoint
NPD1 induces iCa2+ increases in HEK293 cells and MΦs via GPR37.
(A–E) Ca...
(A–E) Ca2+ imaging with the Fura-2AM indicator in HEK293 cells transfected with GPR37 cDNA or empty vector (mock transfection). (A) Representative images showing calcium responses (color changes) after TX14 (1 μM, 3 minute treatment) and NPD1 (30 nM, 3 minute [duration of treatment]) treatment. Scale bar: 50 μm. The pseudo-color scale (0–2) shows the possible range of calcium signaling. (B) Combined traces from 100 cells showing time-dependent iCa2+ increases induced by NPD1 and TX14 after GPR37 but not mock transfection. Arrows show the time points at which the images in A were collected. (C) Comparison of iCa2+ levels after 3 minutes of treatment with NPD1 (30 nM), TX14 (1 μM), RvD1 (100 nM), RvD2 (100 nM), RvE1 (100 nM), lipoxin (100 nM), DHA (1 μM), EPA (1 μM), and ionomycin (2 μM). *P < 0.05 versus baseline (vehicle); 2-way ANOVA followed by Bonferroni’s post hoc test. n = 3–4 cultures, with 73 to 340 cells analyzed for each condition. (D) Dose-response curves of NPD1- and TX14-induced iCa2+ increases. n = 3–4 cultures, with 72 to 250 cells analyzed for each condition. Note the different EC50 values for these 2 compounds. (E) Inhibition of NPD1-induced (30 nM) iCa2+ increases by PTX (1 μg/ml, 16 h before treatment), thapsigargin (1 μM, 3 min), and EGTA (10 mM, 3 min). *P < 0.05; 1-way ANOVA. n = 3–4 cultures, with 131 to 186 cells analyzed per treatment. (F) Dot blots showing a dose-dependent binding of NPD1 and TX14, but not RvE1, to GPR37. The blots were coated with NPD1, TX14, and RvE1 and then incubated with cell lysates from HEK293 cells with GPR37 cDNA or mock transfection. (G–J) Ca2+ imaging with the Fluo-4AM Ca2+ indicator in WT and Gpr37−/− pMΦ cultures. (G) Representative images showing Ca2+ responses (color changes) after NPD1 treatment (30 nM) in WT but not Gpr37−/− mice. Pseudo-color scale (0–5) shows the possible range of calcium signaling. Scale bar: 50 μm. (H) Combined traces from 100 cells showing time-dependent iCa2+ responses after NPD1 treatment (100 nM, 3 min) in WT and Gpr37–/– mice. (I) Comparison of iCa2+ levels after treatment with NPD1 (30 nM, 3 min), TX14 (1 μM, 3 min), PTX (1 μg/ml, 16 h), RvD1 (100 nM, 3 min), RvE1 (100 nM, 3 min), and ATP (100 μM, 3 min) in WT and Gpr37–/– pMΦ cultures. *P < 0.05 versus Gpr37–/–; #P < 0.05 (with PTX vs. without PTX); 2-way ANOVA followed by Bonferroni’s post hoc test. n = 3–4 cultures, with more than 300 cells analyzed for each condition. (J) Dose-response curves of NPD1- and TX14-induced iCa2+ increases in pMΦ cultures. n = 3 cultures, with 80–500 cells analyzed for each condition. Note the different EC50 values for NPD1 and TX14. Data represent the mean ± SEM. F0,relative basal intensity; Fmax, relative peak intensity.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts